JW THERAP-B (02126) announced that on April 20, 2026, the company granted a total of 8.04 million share options under the terms of the company's post-IPO incentive plan adopted on October 14, 2020. Additionally, a total of 220,000 restricted share units were awarded under the company's post-IPO restricted share unit plan, also adopted on October 14, 2020. These awards were granted to 30 designated recipients within the company.